In what could be the biggest boost for Ranbaxy in more than three years, sources suggest that the US FDA has given an approval for Ranbaxy's finished dosage plant in Mohali, reports Archana Shukla of CNBC-TV18.
first published: Nov 30, 2011 05:16 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell
Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live
Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live
Nifty Back Above 26,000 As IT Stocks Sprint Ahead; Nvidia Earnings In Focus| Closing Bell Live
